Drug Injury Lawyers Examine The Possibility of Consolidating Zofran® Drug Injury Lawsuits

by Staff | July 16th, 2015

Many women experience bouts of nausea during pregnancy. There are medications that are available to help treat morning sickness, but our drug injury lawyers at Fleschner, Stark, Tanoos & Newlin explain some of these pharmaceuticals may put the patient’s child at serious risk of birth defects.

Several studies have linked taking the anti-nausea drug, Zofran® while pregnant to children born with serious birth defects. Researchers from three separate teams concluded children who were exposed to Zofran while still in the womb faced an increased risk of congenital heart defects. Still another study found children of mothers who used Zofran while pregnant face two times the risk of being born with a cleft palate.

These conditions, and a lack of information regarding the risks of taking this particular medication, have led to many Zofran drug injury lawsuits being filed by victims. In fact, so many claims have been filed, Reuters reports the manufacturer of the drug, GlaxoSmithKline, has asked the courts to consolidate the cases into one courtroom through multidistrict litigation (MDL).

This move means that more lawsuits are expected to be filed soon. So, if you or your child were harmed as the result of exposure to the drug Zofran, you may wish to speak with a qualified attorney regarding your legal rights to compensation.

At Fleschner, Stark, Tanoos & Newlin, our team of personal injury attorneys are standing by to provide you with answers to any questions you may have. Feel free to contact us anytime by calling (800) 477-7315.

Connect With Our Attorneys Now